For the past year, Endicott has been involved in a fully flexible feedstock development program for the production of biodiesel, which includes algae oil-to-biodiesel commercialization. Among its future development plans are technologies that provide a higher degree of freedom for algae producers in algae strain selection and algae oil extraction for the production of biofuels.
Endicott’s Chief Executive Officer David Robinson said: “We look forward to working with the TransAlgae team, who represent great expertise and experience, to rapidly advance the scale-up and commercialization of algae biofuels production as a high-quality, sustainable fuel source.”
Endicott, through its technology platform, has produced biodiesel at pilot scale using 100% lipids from any animal or vegetable-based feedstock source. The quality of Endicott’s G2 Clear 99 product, which exceeds all ASTM 6751 biodiesel specifications, has been confirmed through independent testing.
“We believe that genetically modified algae provides the best, large-scale, sustainable solution to the multiple resource limitations the global economy is experiencing, providing high-quality alternatives to fossil fuels, petro-chemicals and protein sources without impacting arable land and water,” Noam Gressel, co-founder and board member of TransAlgae, said. “Well designed algal crops can fix carbon dioxide emissions into biological molecules, such as carbohydrates, protein and oil, enabling waste carbon dioxide (CO2) producers to turn a cost into a revenue stream.”
